Autism R&D Pipeline Analysis Report, H2-2018 Therapeutics

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
24
Autism R&D Pipeline Analysis Report, H2-2018 Therapeutics Review

Dublin, Jan. 18, 2019 (GLOBE NEWSWIRE) -- The "Autism R&D Pipeline Analysis Report, H2-2018" report has been added to ResearchAndMarkets.com's offering. The Autism pipeline guide presents complete overview of drugs currently being developed for Autism. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Autism pipeline candidate. Research and Development progress along with latest news related to each of the Autism pipeline candidates is included. Major companies participating in therapeutic development of Autism are included in this pipeline report. Company wise pre clinical and clinical products along with details of drug originator, co developers/ licensors are provided. Amid strong interest for cure of Autism from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Autism clinical and pre clinical products. The report assists in identifying potential upcoming companies and drugs in Autism pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition. Key Topics Covered: I. Key Findings 1. Companies Investing in Autism Pipeline include Number of Companies with Autism projects in pre clinical Development Number of Companies with Autism projects in Clinical Development Autism Pipeline Companies based in Americas Autism Pipeline Companies based in Europe Autism Pipeline Companies based in Asia Pacific Autism Pipeline Companies based in Rest of the World 2. Pipeline Candidates include Autism Pipeline Agents in pre clinical/ Discovery stage of Development Autism Pipeline Agents in Clinical Development stage Autism Pipeline Therapeutic Compounds received special status Mechanism of Action of most pipeline Drugs Small molecules among the Autism Pipeline agents II. Insights into Autism Pipeline - 1. Disease Overview Introduction to Autism Symptoms and Causes of Autism Treatment or Prevention Options for Autism Other Details 2. Phase wise Pipeline Compounds Autism Pipeline Pre Clinical/ Discovery stage Drugs Autism Pipeline Phase 1 stage Drugs Autism Pipeline Phase 2 stage Drugs Autism Pipeline Phase 3 stage Drugs Autism Pipeline Pre Registration stage Drugs 3. Company wise Autism Pipeline Compounds 4. Autism Pipeline by Mechanism of Action III. Autism Pipeline Compound Details Drug Details 1. Snapshot Name of the Therapeutic Agent Originator Developing Company Co Developer/ License Partner Orphan Drug / Fast Track/ Designation Development Phase 2. Drug Overview 3. Mechanism of Action 4. Current Status 5. Clinical Trial Details IV. Autism Pipeline Company Briefs V. Latest News and Developments in Global Autism Pipeline Market VI. Appendix For more information about this report visit https://www.researchandmarkets.com/research/9...randd?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Central Nervous System Drugs

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Red-Eye Flights Surge, Driven By Western U.S. Routes

Updated Category News Views 5

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 3

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Atli Launches: AI-Powered eSIM Revolutionizes Travel

Updated Category News Views 5

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 2

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading
K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Updated Category News Views 7

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 10

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 13

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 6

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading
Havoc, CSBC Partner for Autonomous Maritime Future

Updated Category News Views 6

A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...

Continue Reading
Moore Law Investigates Aardvark Therapeutics' Risks

Updated Category News Views 2

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

Continue Reading

Top 5 Most Recently Viewed Articles

Teleflex's Strategic Move: Separation Into Two Distinct Firms

Updated Category News Views 391

Teleflex's Strategic Separation Initiative In a significant move to enhance shareholder value, Teleflex Incorporated (NYSE: TFX) plans to separate its business into two independent publicly traded entities. This decision follows a comprehensive evaluation of its business portfolio, and the aim is to streamline operations while focusing on core markets. Creating NewCo and...

Continue Reading
Discover the Impressive Returns from Boston Scientific Stock

Updated Category News Views 58

Understanding Boston Scientific's Market Performance Boston Scientific (NYSE: BSX) has been a standout performer in the stock market over the past decade, boasting a remarkable annualized return. Investors who have placed their faith in this innovative medical technology company would be pleased with the results, having realized an annualized growth of 22.01%, which...

Continue Reading
Investigation into Potential Securities Issues at Paysafe Ltd

Updated Category News Views 170

Key Investigation Details on Paysafe Limited Recent developments have brought Paysafe Limited into the spotlight as a law firm initiates an investigation regarding potential securities fraud on behalf of investors. This scrutiny centers on whether the company and its senior management may have breached federal securities laws or engaged in questionable business practices....

Continue Reading
Latham & Watkins' Strategic Moves Spark Asian Market

Updated Category News Views 17

Setting the Stage for Expansion When you hear that Grace Huang and Edward Freeman are hopping onto Latham & Watkins' Hong Kong ship, it's a bit like watching heavyweights enter the ring. Both these pros are bringing a truckload of experience into one of Asia's most competitive markets. This isn't just a small change; it’s a pretty big deal for the firm's capital markets...

Continue Reading
Novele's Groundbreaking Certification for Energy Storage Solutions

Updated Category News Views 189

Novele Achieves Certification Milestone Novele, Inc. has made strides in the energy storage sector by securing important certifications for its innovative EnergyBoard product. These certifications, including Large-Scale Fire Burn VOC, ETL, and CB, highlight the product's compliance with key standards for entry into both North American and European markets. A Memorable...

Continue Reading